Chiho Nakashima

Discontinuation due to immune‐related adverse events is a possible predictive factor for immune checkpoint inhibitors in patients with non‐small cell lung cancer

Kazutoshi Komiya, Tomomi Nakamura, Tomonori Abe et al. · Thoracic Cancer · 2019 · 58 citations · Full text

SPARC is a possible predictive marker for albumin-bound paclitaxel in non-small-cell lung cancer

Kazutoshi Komiya, Tomomi Nakamura, Chiho Nakashima et al. · OncoTargets and Therapy · 2016 · 54 citations · Full text

Investigation of appropriate pre-analytical procedure for circulating free DNA from liquid biopsy

Akemi Sato, Chiho Nakashima, Tomonori Abe et al. · Oncotarget · 2018 · 36 citations · Full text

Mechanisms of acquired resistance to afatinib clarified with liquid biopsy

Tomomi Nakamura, Chiho Nakashima, Kazutoshi Komiya et al. · PLoS ONE · 2018 · 32 citations · Full text

Advanced Lung Disease, Immunology, Pathology +17

Automated DNA extraction using cellulose magnetic beads can improve <i>EGFR</i> point mutation detection with liquid biopsy by efficiently recovering short and long DNA fragments

Chiho Nakashima, Akemi Sato, Tomonori Abe et al. · Oncotarget · 2018 · 29 citations · Full text